Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Premarket Clinical Safety Assessment of the ELISIO™-HX

NCT07058909 is registered in ClinicalTrials.gov with Nipro Medical Corporation as lead sponsor.

NCT NCT07058909
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07058909 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Premarket Clinical Safety Assessment of the ELISIO™-HX
Lead sponsor
Nipro Medical Corporation
Phase
Not applicable
Overall status
Completed
Start date
September 8, 2025
Completion date
February 25, 2026
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute renal failure, chronic kidney diseases, chronic renal failure, end stage renal disease, renal failure